William Blair Downgrades 10x Genomics to Market Perform
William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.
Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday’s Pre-Market Session
Gainers
United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
10X Genomics Reports Q2 Preliminary Revenues, Shares Plummet On Missing Street Expectation
10X Genomics Inc (NASDAQ:TXG) reported preliminary second-quarter revenue is expected to be ~$114.5 million, a decrease of 1% year-over-year, below the…
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
4 Analysts Have This to Say About 10x Genomics
Analysts have provided the following ratings for 10x Genomics (NASDAQ:TXG) within the last quarter:
Morgan Stanley Maintains Overweight on 10x Genomics, Lowers Price Target to $100
Morgan Stanley maintains 10x Genomics (NASDAQ:TXG) with a Overweight and lowers the price target from $135 to $100.
10x Genomics Posts Topline Growth Of 8%, Reaffirms FY22 Guidance
10x Genomics (NASDAQ: TXG) reported
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.